Roll call on Senate Bill 875
Excepting xylazine testing materials from the definition of drug paraphernalia and civil and criminal liability exemptions for distributing and administering xylazine testing products.
Senate Committee on Mental Health vote to recommend it
Passed, 5 to 0 · Feb 2, 2024
No member-by-member record exists for this vote. Committee votes and some older sessions record totals only.
Official motion: “Report passage recommended by Committee on Mental Health, Substance Abuse Prevention, Children and Families, Ayes 5, Noes 0”. Official record